 |
PDBsum entry 1ib9
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Plant protein
|
PDB id
|
|
|
|
1ib9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:22875-22882
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis.
|
|
M.E.Felizmenio-Quimio,
N.L.Daly,
D.J.Craik.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Much interest has been generated by recent reports on the discovery of circular
(i.e. head-to-tail cyclized) proteins in plants. Here we report the
three-dimensional structure of one of the newest such circular proteins,
MCoTI-II, a novel trypsin inhibitor from Momordica cochinchinensis, a member of
the Cucurbitaceae plant family. The structure consists of a small beta-sheet,
several turns, and a cystine knot arrangement of the three disulfide bonds.
Interestingly, the molecular topology is similar to that of the plant cyclotides
(Craik, D. J., Daly, N. L., Bond, T., and Waine, C. (1999) J. Mol. Biol. 294,
1327-1336), which derive from the Rubiaceae and Violaceae plant families, have
antimicrobial activities, and exemplify the cyclic cystine knot structural motif
as part of their circular backbone. The sequence, biological activity, and plant
family of MCoTI-II are all different from known cyclotides. However, given the
structural similarity, cyclic backbone, and plant origin of MCoTI-II, we propose
that MCoTI-II can be classified as a new member of the cyclotide class of
proteins. The expansion of the cyclotides to include trypsin inhibitory activity
and a new plant family highlights the importance and functional variability of
circular proteins and the fact that they are more common than has previously
been believed. Insights into the possible roles of backbone cyclization have
been gained by a comparison of the structure of MCoTI-II with the homologous
acyclic trypsin inhibitors CMTI-I and EETI-II from the Cucurbitaceae plant
family.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Comparison of the and aspartyl
isomers of MCoTI-II. a, structure of and aspartic
acid residues and sequential NOEs expected to be observed in the
-Asp form.
b, comparison of the -proton
chemical shifts of the two isomers of MCoTI-II. The fact that
the differences occur only near residue Asp-5 suggests that
isomerization of this residue ( / aspartic
acid) is responsible for the differences between the two
isolated peptides.
|
 |
Figure 8.
Fig. 8. The three-dimensional structure of MCoTI-II shown
in CPK format. The negatively charged residues are in red,
positively charged in dark blue, hydrophobic residues in green,
polar residues in light blue, and cysteine residues in yellow.
Surface exposed hydrophobic residues appear mainly on one face
and the other face contains most of the positively and
negatively charged residues. The views are rotated 180°
about the vertical axis with respect to each other. The diagram
was generated using MOLMOL (39).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
22875-22882)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.L.Arolas,
and
S.Ventura
(2011).
Protease inhibitors as models for the study of oxidative folding.
|
| |
Antioxid Redox Signal,
14,
97.
|
 |
|
|
|
|
 |
N.L.Daly,
K.J.Rosengren,
S.T.Henriques,
and
D.J.Craik
(2011).
NMR and protein structure in drug design: application to cyclotides and conotoxins.
|
| |
Eur Biophys J,
40,
359-370.
|
 |
|
|
|
|
 |
L.Cascales,
and
D.J.Craik
(2010).
Naturally occurring circular proteins: distribution, biosynthesis and evolution.
|
| |
Org Biomol Chem,
8,
5035-5047.
|
 |
|
|
|
|
 |
R.J.Clark,
and
D.J.Craik
(2010).
Invited reviewnative chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins.
|
| |
Biopolymers,
94,
414-422.
|
 |
|
|
|
|
 |
S.S.Puttamadappa,
K.Jagadish,
A.Shekhtman,
and
J.A.Camarero
(2010).
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin.
|
| |
Angew Chem Int Ed Engl,
49,
7030-7034.
|
 |
|
|
|
|
 |
D.J.Craik
(2009).
Circling the enemy: cyclic proteins in plant defence.
|
| |
Trends Plant Sci,
14,
328-335.
|
 |
|
|
|
|
 |
J.A.McIntosh,
M.S.Donia,
and
E.W.Schmidt
(2009).
Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.
|
| |
Nat Prod Rep,
26,
537-559.
|
 |
|
|
|
|
 |
J.Austin,
W.Wang,
S.Puttamadappa,
A.Shekhtman,
and
J.A.Camarero
(2009).
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I.
|
| |
Chembiochem,
10,
2663-2670.
|
 |
|
|
|
|
 |
S.Gunasekera,
N.L.Daly,
R.J.Clark,
and
D.J.Craik
(2009).
Dissecting the oxidative folding of circular cystine knot miniproteins.
|
| |
Antioxid Redox Signal,
11,
971-980.
|
 |
|
|
|
|
 |
A.Heitz,
O.Avrutina,
D.Le-Nguyen,
U.Diederichsen,
J.F.Hernandez,
J.Gracy,
H.Kolmar,
and
L.Chiche
(2008).
Knottin cyclization: Impact on Structure and Dynamics.
|
| |
BMC Struct Biol,
8,
54.
|
 |
|
|
|
|
 |
C.Combelles,
J.Gracy,
A.Heitz,
D.J.Craik,
and
L.Chiche
(2008).
Structure and folding of disulfide-rich miniproteins: insights from molecular dynamics simulations and MM-PBSA free energy calculations.
|
| |
Proteins,
73,
87.
|
 |
|
|
|
|
 |
C.K.Wang,
Q.Kaas,
L.Chiche,
and
D.J.Craik
(2008).
CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering.
|
| |
Nucleic Acids Res,
36,
D206-D210.
|
 |
|
|
|
|
 |
D.C.Ireland,
C.K.Wang,
J.A.Wilson,
K.R.Gustafson,
and
D.J.Craik
(2008).
Cyclotides as natural anti-HIV agents.
|
| |
Biopolymers,
90,
51-60.
|
 |
|
|
|
|
 |
H.Dörnenburg
(2008).
Plant cell culture technology-harnessing a biological approach for competitive cyclotides production.
|
| |
Biotechnol Lett,
30,
1311-1321.
|
 |
|
|
|
|
 |
M.Cemazar,
A.Joshi,
N.L.Daly,
A.E.Mark,
and
D.J.Craik
(2008).
The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein.
|
| |
Structure,
16,
842-851.
|
 |
|
|
|
|
 |
M.Cemazar,
C.W.Gruber,
and
D.J.Craik
(2008).
Oxidative folding of cyclic cystine knot proteins.
|
| |
Antioxid Redox Signal,
10,
103-112.
|
 |
|
|
|
|
 |
N.Farrokhi,
J.P.Whitelegge,
and
J.A.Brusslan
(2008).
Plant peptides and peptidomics.
|
| |
Plant Biotechnol J,
6,
105-134.
|
 |
|
|
|
|
 |
O.Avrutina,
H.U.Schmoldt,
D.Gabrijelcic-Geiger,
A.Wentzel,
H.Frauendorf,
C.P.Sommerhoff,
U.Diederichsen,
and
H.Kolmar
(2008).
Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis.
|
| |
Chembiochem,
9,
33-37.
|
 |
|
|
|
|
 |
P.Thongyoo,
N.Roqué-Rosell,
R.J.Leatherbarrow,
and
E.W.Tate
(2008).
Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides.
|
| |
Org Biomol Chem,
6,
1462-1470.
|
 |
|
|
|
|
 |
D.J.Craik,
and
N.L.Daly
(2007).
NMR as a tool for elucidating the structures of circular and knotted proteins.
|
| |
Mol Biosyst,
3,
257-265.
|
 |
|
|
|
|
 |
D.J.Craik,
R.J.Clark,
and
N.L.Daly
(2007).
Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins.
|
| |
Expert Opin Investig Drugs,
16,
595-604.
|
 |
|
|
|
|
 |
J.A.Camarero,
R.H.Kimura,
Y.H.Woo,
A.Shekhtman,
and
J.Cantor
(2007).
Biosynthesis of a fully functional cyclotide inside living bacterial cells.
|
| |
Chembiochem,
8,
1363-1366.
|
 |
|
|
|
|
 |
M.R.Plan,
U.Göransson,
R.J.Clark,
N.L.Daly,
M.L.Colgrave,
and
D.J.Craik
(2007).
The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.
|
| |
Chembiochem,
8,
1001-1011.
|
 |
|
|
|
|
 |
P.Thongyoo,
A.M.Jaulent,
E.W.Tate,
and
R.J.Leatherbarrow
(2007).
Immobilized protease-assisted synthesis of engineered cysteine-knot microproteins.
|
| |
Chembiochem,
8,
1107-1109.
|
 |
|
|
|
|
 |
D.J.Craik,
M.Cemazar,
C.K.Wang,
and
N.L.Daly
(2006).
The cyclotide family of circular miniproteins: nature's combinatorial peptide template.
|
| |
Biopolymers,
84,
250-266.
|
 |
|
|
|
|
 |
J.P.Mulvenna,
C.Wang,
and
D.J.Craik
(2006).
CyBase: a database of cyclic protein sequence and structure.
|
| |
Nucleic Acids Res,
34,
D192-D194.
|
 |
|
|
|
|
 |
P.Thongyoo,
E.W.Tate,
and
R.J.Leatherbarrow
(2006).
Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II.
|
| |
Chem Commun (Camb),
(),
2848-2850.
|
 |
|
|
|
|
 |
Z.O.Shenkarev,
K.D.Nadezhdin,
V.A.Sobol,
A.G.Sobol,
L.Skjeldal,
and
A.S.Arseniev
(2006).
Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
|
| |
FEBS J,
273,
2658-2672.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
O.Avrutina,
H.U.Schmoldt,
D.Gabrijelcic-Geiger,
D.Le Nguyen,
C.P.Sommerhoff,
U.Diederichsen,
and
H.Kolmar
(2005).
Trypsin inhibition by macrocyclic and open-chain variants of the squash inhibitor MCoTI-II.
|
| |
Biol Chem,
386,
1301-1306.
|
 |
|
|
|
|
 |
D.J.Craik,
N.L.Daly,
I.Saska,
M.Trabi,
and
K.J.Rosengren
(2003).
Structures of naturally occurring circular proteins from bacteria.
|
| |
J Bacteriol,
185,
4011-4021.
|
 |
|
|
|
|
 |
A.Hofmann,
H.Iwai,
S.Hess,
A.Plückthun,
and
A.Wlodawer
(2002).
Structure of cyclized green fluorescent protein.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
1400-1406.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Trabi,
and
D.J.Craik
(2002).
Circular proteins--no end in sight.
|
| |
Trends Biochem Sci,
27,
132-138.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |